471 related articles for article (PubMed ID: 11777627)
21. 3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.
Ren YF; Gao YH; Cao XP; Ye WJ; Teh BS
Radiat Oncol; 2010 Nov; 5():113. PubMed ID: 21092297
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
[TBL] [Abstract][Full Text] [Related]
23. Addition of intracavitary brachytherapy to external beam radiation therapy for T1-T2 nasopharyngeal carcinoma.
Wu J; Guo Q; Lu JJ; Zhang C; Zhang X; Pan J; Tham IW
Brachytherapy; 2013; 12(5):479-86. PubMed ID: 23466362
[TBL] [Abstract][Full Text] [Related]
24. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
25. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience.
Lee N; Hoffman R; Phillips TL; Xia P; Quivey JM; Weinberg V; Hsu IC
Brachytherapy; 2002; 1(2):74-82. PubMed ID: 15062174
[TBL] [Abstract][Full Text] [Related]
26. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
27. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
28. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
[TBL] [Abstract][Full Text] [Related]
29. The role of brachytherapy in early-stage nasopharyngeal carcinoma.
Chang JT; See LC; Tang SG; Lee SP; Wang CC; Hong JH
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1019-24. PubMed ID: 8985022
[TBL] [Abstract][Full Text] [Related]
30. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns.
Leung TW; Tung SY; Sze WK; Wong FC; Yuen KK; Lui CM; Lo SH; Ng TY; O SK
Head Neck; 2005 Jul; 27(7):555-65. PubMed ID: 15880410
[TBL] [Abstract][Full Text] [Related]
31. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
[TBL] [Abstract][Full Text] [Related]
32. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
33. [Postoperative radiotherapy in endometrial carcinoma. A retrospective analysis of 541 cases].
Hänsgen G; Nagel M; Dunst J; Enke H
Strahlenther Onkol; 1999 Nov; 175(11):548-53. PubMed ID: 10584124
[TBL] [Abstract][Full Text] [Related]
34. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
[TBL] [Abstract][Full Text] [Related]
35. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant high-dose rate brachytherapy after chemoradiation for treatment of early T-stage nasopharyngeal carcinoma.
Lu JJ; Shakespeare T; Goh BC; Tiong CE; Back M; Mukherjee R; Wynne CJ; Tan KS
Am J Clin Oncol; 2004 Apr; 27(2):132-5. PubMed ID: 15057151
[TBL] [Abstract][Full Text] [Related]
38. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
39. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
Tan LT; Jones B; Gee A; Kingston RE
Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
[TBL] [Abstract][Full Text] [Related]
40. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]